| __timestamp | Bio-Techne Corporation | Lantheus Holdings, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 251411000 | 125519000 |
| Thursday, January 1, 2015 | 307277000 | 135522000 |
| Friday, January 1, 2016 | 336659000 | 137780000 |
| Sunday, January 1, 2017 | 374541000 | 162135000 |
| Monday, January 1, 2018 | 432143000 | 174885000 |
| Tuesday, January 1, 2019 | 473491000 | 174811000 |
| Wednesday, January 1, 2020 | 483194000 | 138761000 |
| Friday, January 1, 2021 | 632850000 | 187695000 |
| Saturday, January 1, 2022 | 756496000 | 581703000 |
| Sunday, January 1, 2023 | 769815000 | 709543000 |
| Monday, January 1, 2024 | 769725000 |
Cracking the code
In the ever-evolving landscape of biotechnology, financial performance is a key indicator of a company's health and potential. This analysis delves into the gross profit trends of two prominent players: Bio-Techne Corporation and Lantheus Holdings, Inc., from 2014 to 2023.
Bio-Techne Corporation has demonstrated a robust growth trajectory, with its gross profit increasing by over 200% from 2014 to 2023. Notably, the company saw a significant surge in 2021, with profits jumping by approximately 31% compared to the previous year. Meanwhile, Lantheus Holdings, Inc. experienced a remarkable 465% increase in gross profit from 2014 to 2023, with a substantial leap in 2022, marking a 210% rise from 2021.
These trends underscore the dynamic nature of the biotech industry, where innovation and strategic investments drive financial success. However, it's important to note that data for 2024 is incomplete, reflecting the unpredictable nature of market conditions.
Key Insights on Gross Profit: Eli Lilly and Company vs Bio-Techne Corporation
Amgen Inc. and Bio-Techne Corporation: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Sanofi vs Bio-Techne Corporation
Who Generates Higher Gross Profit? Vertex Pharmaceuticals Incorporated or Lantheus Holdings, Inc.
Who Generates Higher Gross Profit? GSK plc or Bio-Techne Corporation
Genmab A/S vs Bio-Techne Corporation: A Gross Profit Performance Breakdown
Genmab A/S and Lantheus Holdings, Inc.: A Detailed Gross Profit Analysis
Incyte Corporation vs Lantheus Holdings, Inc.: A Gross Profit Performance Breakdown
Bio-Techne Corporation vs Ascendis Pharma A/S: A Gross Profit Performance Breakdown
Bio-Techne Corporation vs Lantheus Holdings, Inc.: Efficiency in Cost of Revenue Explored
Bio-Techne Corporation and Halozyme Therapeutics, Inc.: A Detailed Gross Profit Analysis
Key Insights on Gross Profit: Lantheus Holdings, Inc. vs Amneal Pharmaceuticals, Inc.